in favourable incremental cost - effectiveness ratios ( ICERsresultedin favourable incremental cost - effectiveness ratios ( ICERs

to further improvement in immunity in 66/115 ( 57 %ledto further improvement in immunity in 66/115 ( 57 %

travel - associated C. diphtheriae infectionto preventtravel - associated C. diphtheriae infection

serotonin syndrome , a rare but potentially serious ; other effects such to 26 milligrams ( e.g. , 6 days after more likely to experience anginamay causeserotonin syndrome , a rare but potentially serious ; other effects such to 26 milligrams ( e.g. , 6 days after more likely to experience angina

Diphtheria , Tetanus and Pertussis To prevent Japanese Encephalitis 2 doses , at 1 year after birth ( two weeks apartTo preventDiphtheria , Tetanus and Pertussis To prevent Japanese Encephalitis 2 doses , at 1 year after birth ( two weeks apart

your body to build more immunity against the diseasecausesyour body to build more immunity against the disease

in a high antibody concentrationresultedin a high antibody concentration

to provide additional protection from the diseasesdesignedto provide additional protection from the diseases

a secondary immune response and the production of more long - lived plasma cellscausesa secondary immune response and the production of more long - lived plasma cells

the loss of immunity that happens over timeto preventthe loss of immunity that happens over time

pertussis ( whooping cough ) , which is now common in Western North Carolina because of lower vaccination rates in childrento preventpertussis ( whooping cough ) , which is now common in Western North Carolina because of lower vaccination rates in children

in favourable ICERsalways resultedin favourable ICERs

in favorable ICERs ( < € 10,000 / QALYalways resultedin favorable ICERs ( < € 10,000 / QALY

to a pronounced increase in GMTs and seroprotection rateledto a pronounced increase in GMTs and seroprotection rate

this serious disease that has no treatment and substantial mortality ratesto preventthis serious disease that has no treatment and substantial mortality rates

in better control and prevention of the diseaseresultedin better control and prevention of the disease

disease in these individualswould have preventeddisease in these individuals

to an earlier reduction of vaccine serotype carriage in particular for lower immunogenic serotypes like serotype 6B or for serotypes requiring high antibody levels such as serotype 19F,10,28 but may not be necessary for long - term carriage reductionmay contributeto an earlier reduction of vaccine serotype carriage in particular for lower immunogenic serotypes like serotype 6B or for serotypes requiring high antibody levels such as serotype 19F,10,28 but may not be necessary for long - term carriage reduction

in higher IFN - γ ( the immune system product associated with protective immunity to Brucella ) responsesresultedin higher IFN - γ ( the immune system product associated with protective immunity to Brucella ) responses

The predominant effect in coma and respiratory depression(passive) caused byThe predominant effect in coma and respiratory depression

you laid - upcan ... influenceyou laid - up

in 91 of 99 participantsresultedin 91 of 99 participants

at least three of these cases(passive) could have been prevented byat least three of these cases

in an earlier further reduction of vaccine serotype carriage at 18 months compared with no booster doseresultedin an earlier further reduction of vaccine serotype carriage at 18 months compared with no booster dose

in lower rates of VT carriageresultedin lower rates of VT carriage

to the body makingledto the body making

in an anamnestic responseresultedin an anamnestic response

tetanus  Postexposure prevention of tetanus Other : chills , anaphylaxis Mechanism of Action y Contraindications Contraindicated in immunosuppressed patients , in those with immunoglobulin abnormalities , and in those with severe hypersensitivity or neurologic reactions to toxoid or its ingredientsto preventtetanus  Postexposure prevention of tetanus Other : chills , anaphylaxis Mechanism of Action y Contraindications Contraindicated in immunosuppressed patients , in those with immunoglobulin abnormalities , and in those with severe hypersensitivity or neurologic reactions to toxoid or its ingredients

in a broadening of the gap between the government ’s income and expenditurehad resultedin a broadening of the gap between the government ’s income and expenditure